Section: PHARMACOGENOMICS
Organizing Secretary: Charles R. Cantor
Chief Scientific Officer
SEQUENOM, Inc., USA
|
INVITED LECTURES
|
Abstract Awaited
Charles R. Cantor
Chief Scientific Officer, SEQUENOM, Inc., USA
|
| A Clinical Pharmacogenetic Model to Predict
the Efficacy of Methotrexate Monotherapy in Recent Onset
Rheumatoid Arthritis
H.-J. Guchelaar
Clinical Pharmacy and Toxicology, Leiden University
Medical Center, The Netherlands
|
| The Effects of Genes Related to the Monoaminergic
Pathways on the Action of Antidepressants
Min-Soo Lee
Depression Center, Clinical Research Center for
Depression, Pharmacogenomic Research Center for Psychotropic
Drugs, South Korea
|
| A New Era of Medicine “Genomic Medicine”:
Gonnecting Genes, Drugs and Diseases
Abdelali Haoudi
Vice President for Research, Qatar Foundation,
Qatar
|
| Translational Approach to Study Anti-Cancer
Drugs Using Mouse Model of Breast Cancer
Toru Ouchi
ENH, Feinberg School of Medicine, The Robert H.
Lurie Comprehensive Cancer Center, USA
|
|
